FDA Awards Clearance for LungVision Navigation System to Revolutionize the Treatment of Lung Lesions

Medical device company Body Vision Medical reported on Monday the receipt of clearance from the U.S. Food and Drug Administration (FDA) to market its first LungVision platform to the medical community to revolutionize, diagnose and treat peripheral lung lesions.

LungVision, which is a novel imaging system that enables accurate real-time navigation and lesion localization during bronchoscopic procedures, demonstrated outstanding results through the company’s multicenter clinical trials in the U.S.

Utilizing a sophisticated augmented reality approach, LungVision allows

Leave a Comment

Your email address will not be published. Required fields are marked *